Neuroendocrine tumors other imaging findings: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Neuroendocrine tumors}} {{CMG}} == Overview == ==Other Imaging Findings== The diagnostic procedure that utilizes a somatostatin analog is the OctreoScan, also ca...")
 
No edit summary
Line 6: Line 6:


==Other Imaging Findings==
==Other Imaging Findings==
===Octreoscan===
The diagnostic procedure that utilizes a somatostatin analog is the OctreoScan, also called somatostatin receptor scintigraphy (SRS or SSRS): a patient is injected with octreotide chemically bound to a radioactive substance, often [[indium]]-111; for those patients whose tumor cells are avid for octreotide, a radiation-sensitive scan can then indicate the locations of the larger lesions.
The diagnostic procedure that utilizes a somatostatin analog is the OctreoScan, also called somatostatin receptor scintigraphy (SRS or SSRS): a patient is injected with octreotide chemically bound to a radioactive substance, often [[indium]]-111; for those patients whose tumor cells are avid for octreotide, a radiation-sensitive scan can then indicate the locations of the larger lesions.
An OctreoScan is a relatively crude test that generates subjective results.
===PET-CT Scan===
A [[gallium]]-68 receptor [[positron emission tomography|PET]]-CT, integrating a PET image with a CT image, is much more senstitive than an OctreoScan, and it generates objective (quantified) results in the form of a standardized uptake value (SUV).


==References==
==References==

Revision as of 19:55, 30 August 2012

Neuroendocrine tumors Microchapters

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk factors

Natural History, Complications and Prognosis

History and Symptoms

Laboratory Findings

CT scan

PET scan

Medical Therapy

Surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Other Imaging Findings

Octreoscan

The diagnostic procedure that utilizes a somatostatin analog is the OctreoScan, also called somatostatin receptor scintigraphy (SRS or SSRS): a patient is injected with octreotide chemically bound to a radioactive substance, often indium-111; for those patients whose tumor cells are avid for octreotide, a radiation-sensitive scan can then indicate the locations of the larger lesions.

An OctreoScan is a relatively crude test that generates subjective results.

PET-CT Scan

A gallium-68 receptor PET-CT, integrating a PET image with a CT image, is much more senstitive than an OctreoScan, and it generates objective (quantified) results in the form of a standardized uptake value (SUV).

References

Template:WH Template:WS